Genotype-phenotype correlation in Italian children with Wilson's disease.

BACKGROUND/AIMS Wilson's disease phenotype is very variable for clinical and laboratory features. Our aim was to assess the role of the type of ATP7B disease causing mutations on Wilson's disease phenotype. METHODS We retrospectively evaluated the data of children with Wilson's disease from eight pediatric departments. RESULT Fifty-eight patients (34 male, median age at diagnosis 7.4 years) from 47 unrelated families were studied, carrying 34 different mutations. The most common mutations were the missense p.H1069Q and p.M769V, the nonsense p.R1319X, the frameshift c.2299delC, c.2298_2299insC and c.2530delA, and the splice site mutation c.2447+5G>A. Serum ceruloplasmin and copper were lower among the patients' homozygotes for nonsense and frameshift mutations than in patients with missense mutations. A normalization of serum alanine aminotransferase after therapy was not achieved in 23.6% of patients with missense mutations versus 45.5% of patients with nonsense/frameshift mutations. A direct linear correlation was found between age at diagnosis and urinary copper excretion at diagnosis. CONCLUSIONS The type of mutation explains at least a part of Wilson's disease phenotype, and mutation analysis should be considered as an integrative tool for such a challenging diagnosis. Urinary copper excretion appears to be correlated to the age at diagnosis rather than genotype.

[1]  D. Cox,et al.  Diagnosis and phenotypic classification of Wilson disease 1 , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[2]  R. Palmiter,et al.  A murine model of Menkes disease reveals a physiological function of metallothionein , 1996, Nature Genetics.

[3]  C. Datz,et al.  Detection of the His1069Gln Mutation in Wilson Disease by Rapid Polymerase Chain Reaction , 1997, Annals of Internal Medicine.

[4]  M. Pastore,et al.  Persistence of elevated aminotransferases in Wilson's disease despite adequate theraphy. , 2004, Hepatology.

[5]  T. Gilliam,et al.  Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. , 1994, Human molecular genetics.

[6]  H. Hefter,et al.  His1069Gln and six novel Wilson disease mutations: analysis of relevance for early diagnosis and phenotype , 1998, European Journal of Human Genetics.

[7]  N. Kasai,et al.  Effects of sex hormones on fulminant hepatitis in LEC rats: a model of Wilson's disease. , 1992, Laboratory animal science.

[8]  I. Ovchinnikov,et al.  The His1069Gln mutation in the ATP7B gene in Russian patients with Wilson disease , 1999, Journal of medical genetics.

[9]  U. Landegren,et al.  Efficient detection of mutations in Wilson disease by manifold sequencing. , 1996, Genomics.

[10]  J. Peppercorn,et al.  The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene , 1993, Nature Genetics.

[11]  A. Członkowska,et al.  Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease , 2005, Clinical genetics.

[12]  D. Cox,et al.  Copper-dependent trafficking of Wilson disease mutant ATP7B proteins. , 2000, Human molecular genetics.

[13]  M. T. Pellecchia,et al.  Twenty-four novel mutations in Wilson disease patients of predominantly Italian origin. , 2007, Genetic testing.

[14]  A. Członkowska,et al.  Very high frequency of the His1069Gln mutation in Polish Wilson disease patients , 1997, Journal of Neurology.

[15]  M. Sinaasappel,et al.  Oral zinc sulphate for Wilson's disease. , 1985, Archives of disease in childhood.

[16]  C. Madl,et al.  The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. , 2000, Brain : a journal of neurology.

[17]  L. H. van den Berg,et al.  The H1069Q mutation in ATP7B is associated with late and neurologic presentation in Wilson disease: results of a meta-analysis. , 2004, Journal of hepatology.

[18]  M. Tzetis,et al.  Genotype–phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B) , 2004, American journal of medical genetics. Part A.

[19]  F. Dati,et al.  Referenzwerte für 18 Plasmaproteine am Behring-Nephelometer-System , 1989 .

[20]  M. Rodo,et al.  Frequency of His1069Gln and Gly1267Lys mutations in Polish Wilson's Disease population , 2000, European journal of neurology.

[21]  N. McIntyre,et al.  Molecular diagnosis of Wilson disease. , 2001, Molecular genetics and metabolism.

[22]  J. Mössner,et al.  High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. , 2001, Journal of hepatology.

[23]  A. Angius,et al.  Mutation analysis in patients of Mediterranean descent with Wilson disease: identification of 19 novel mutations , 1999, Journal of medical genetics.

[24]  S. Tanner Disorders of Copper Metabolism , 2007 .

[25]  J. Rommens,et al.  The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene , 1993, Nature Genetics.

[26]  B. Portmann,et al.  Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease , 1992, Hepatology.

[27]  K. Ashkan,et al.  Wilson's disease , 2007, The Lancet.

[28]  A. K. A. GIJSBERTI HODENPIJL [Wilson's disease]. , 1950, Maandschrift voor kindergeneeskunde.

[29]  T. Gilliam,et al.  Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. , 1997, American journal of human genetics.

[30]  M. Sinaasappel,et al.  Wilson's disease: assessment of D-penicillamine treatment. , 1985, Archives of disease in childhood.

[31]  H. Kingston,et al.  Microwave energy for acid decomposition at elevated temperatures and pressures using biological and botanical samples. , 1986, Analytical chemistry.

[32]  A. Vegnente,et al.  Wilson disease: diagnostic dilemmas? , 2000, Journal of pediatric gastroenterology and nutrition.

[33]  V. Kostic,et al.  Characterization of the molecular defect in the ATP7B gene in Wilson disease patients from Yugoslavia. , 2003, Genetic testing.

[34]  T. Glant,et al.  Common mutations of ATP7B in Wilson disease patients from Hungary. , 2002, American journal of medical genetics.

[35]  M. Schilsky,et al.  A practice guideline on Wilson disease , 2003, Hepatology.

[36]  Deirdre A. Kelly,et al.  Diseases of the Liver and Biliary System in Children , 2000 .